Upon the approval of the 2016 fiscal year budget, Congress has agreed to remarkably increase government funding on Alzheimer’s disease research by 50% this year, which is an additional $350 million dollars from the previous budget. Although the amount is still relatively small compared to research on other diseases, this is considered a tremendous victory for healthcare advocates across the United States.
“Congressional champions from both sides of the aisle have heard the appeals from leading scientists convened by the Alzheimer's Association and the hundreds of thousands of advocates we have led,” President and CEO of the Alzheimer’s Association Harry Johns stated last month. “They have answered with a bold, strategic decision to invest in the fight against Alzheimer's disease, which is a necessary next step in our country's journey to end this epidemic.”
Alzheimer’s care can be significantly challenging on family members and caregivers. According to the Alzheimer’s Association, 5.3 million Americans are currently living with the disease. While some medication is available, a cure has not been discovered yet. An increase of research money from the federal government signals a colossal step in the fight against Alzheimer’s, spending must continue to rise to effectively alleviate the burgeoning costs of medication and treatment.